momelotinib for the treatment of myelofibrosis
Published 4 years ago • 201 plays • Length 1:40Download video MP4
Download video MP3
Similar videos
-
3:00
the promise of momelotinib in the treatment of myelofibrosis
-
1:26
updates on the use of momelotinib for the treatment of mf & clinical trials evaluating this agent
-
1:53
recent updates from the momentum trial and the value of momelotinib for the treatment of mf
-
3:03
an insight into the momentum trial: safety and efficacy of momelotinib for the treatment of mf
-
3:43
momelotinib: a promising drug for patients with myelofibrosis
-
2:16
long-term safety of momelotinib for myelofibrosis
-
4:25
update on momelotinib for myelofibrosis
-
4:36
being marilyn…with myelofibrosis—an mf journey
-
4:49
myelofibrosis - causes, symptoms, diagnosis, treatment, pathology
-
3:48
efficacy of momelotinib in thrombocytopenic patients with myelofibrosis from momentum
-
22:26
what's your approach? treating myelofibrosis
-
2:07
analysis of long-term exposure to momelotinib in the phase iii simplfy myelofibrosis trials
-
1:16
indirect comparison of the safety of momelotinib vs fedratinib in patients with myelofibrosis
-
1:38
pelabresib plus ruxolitinib for the treatment of intermediate- and high-risk myelofibrosis
-
1:01
latest advances in myelofibrosis treatment
-
3:19
first-line treatment selection in myelofibrosis
-
2:51
ruxolitinib in combination with abemaciclib for patients with primary or post-pv/et myelofibrosis
-
2:12
navtemadlin and its role in the treatment of r/r myelofibrosis
-
1:15
exploring the evolving treatment landscape of myelofibrosis
-
1:01
clinical outcomes for patients with myelofibrosis after transition from ruxolitinib to momelotinib
-
2:10
phase i study of ruxolitinib in combination with abemaciclib in patients with myelofibrosis
-
1:15
ongoing trials of ruxolitinib, momelotinib and imetelstat in myelofibrosis